HALEY DUFF

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CLARKSVILLE, AR NPI 1396304697

General Payments — all program years on this page

$1,129.25

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 66
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $352.56 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $352.5620

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $92.256
GlaxoSmithKline, LLC. $87.614
Lilly USA, LLC $63.964
PFIZER INC. $52.823
Acerta Pharma LLC $26.841
Novo Nordisk AS $14.861
Xeris Pharmaceuticals, Inc. $14.221

By program year

Program yearAmountRecords
2021 $170.7512
2022 $326.2517
2023 $279.6917
2024 $352.5620

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100241822 Novo Nordisk Inc $14.86 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105609391 AstraZeneca Pharmaceuticals LP $26.84 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045420 ABBVIE INC. $14.08 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045422 ABBVIE INC. $14.17 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045424 ABBVIE INC. $14.96 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045426 ABBVIE INC. $19.13 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045428 ABBVIE INC. $15.74 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107045430 ABBVIE INC. $14.17 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116297530 GlaxoSmithKline, LLC. $18.86 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116307557 GlaxoSmithKline, LLC. $22.05 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116459873 GlaxoSmithKline, LLC. $24.99 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116504249 GlaxoSmithKline, LLC. $21.71 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131602532 PFIZER INC. $20.19 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131662794 PFIZER INC. $14.24 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131969590 PFIZER INC. $18.39 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135639942 Lilly USA, LLC $15.65 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135639944 Lilly USA, LLC $16.79 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135651827 Lilly USA, LLC $13.96 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135686245 Lilly USA, LLC $17.56 05/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144626745 Xeris Pharmaceuticals, Inc. $14.22 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.